Back to search
FDAFDA · Food and drugs·Recall number D-1662-2012

Leflunomide tablets, 20 mg, 1000-count bottle, Rx only, Manufactured for Apotex Corp., Weston, Florida 33326 by Apotex Inc., Toronto, Ontario Canada M9L 1T9, NDC 60505-2503-3

Published September 5, 2012 · Recall initiated: June 14, 2007

Summary

FDA records drug Class II recall D-1662-2012, published September 5, 2012 and initiated June 14, 2007. Recalling firm: Apotex Corp.; Status: Terminated; Reported quantity: 31; Lot: Lot #: GZ1274, Exp 11/07. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent (Single Ingredient Drug): Distribution of product that did not meet specifications.

What to do

Voluntary: Firm initiated · FAX

Get an email if LEFLUNOMIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LEFLUNOMIDE
Manufacturer
Apotex Corp.
Distributor
Nationwide.
Lot
Lot #: GZ1274, Exp 11/07.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Leflunomide tablets, 20 mg, 1000-count bottle, Rx only, Manufactured for Apotex Corp., Weston, Florida 33326 by Apotex Inc., Toronto, Ontario Canada M9L 1T9, NDC 60505-2503-3 recalled?

Yes. FDA published recall D-1662-2012 on September 5, 2012. Reported hazard: Subpotent (Single Ingredient Drug): Distribution of product that did not meet specifications.

What should I do if I have this product?

Voluntary: Firm initiated · FAX

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LEFLUNOMIDE.